tiprankstipranks
Trending News
More News >
Vivoryon Therapeutics AG (DE:05Y)
:05Y
Germany Market

Vivoryon Therapeutics AG (05Y) Cash flow

Compare
36 Followers

Vivoryon Therapeutics AG Cash Flow

DE:05Y's free cash flow for Q2 2025 was €-4.50M. For the 2025 fiscal year, DE:05Y's free cash flow was decreased by €2.88M and operating cash flow was €-4.50M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
€ -19.17M€ -21.54M€ -21.79M€ -11.26M€ -14.01M
Investing Cash Flow
€ 10.00M€ -10.51M€ -13.00K€ -28.00K€ -640.00K
Financing Cash Flow
€ -57.00K€ 24.16M€ 33.38M€ -827.00K€ -90.00K
End Cash Position
€ 9.37M€ 18.56M€ 26.55M€ 14.66M€ 26.31M
Free Cash Flow
€ -19.18M€ -22.05M€ -21.81M€ -11.29M€ -14.65M
Currency in EUR

Vivoryon Therapeutics AG Cash Flow